# Purification, Structural Characterization, and Immunomodulatory Activity of Polysaccharides from Cinnamomum cassia

**Authors:** Jinya Dong, Peng Zhang, Subramanian Palanisamy, Huajie Yin, Qiyuan Zhang, Chongye Fang, SangGuan You, Yunfei Ge

PMC · DOI: 10.3390/foods15050927 · 2026-03-06

## TL;DR

This study isolates and characterizes two polysaccharides from Cinnamomum cassia, finding that one, F2, strongly activates immune cells and could be useful in functional foods or medicine.

## Contribution

The novel contribution is the detailed structural and functional characterization of C. cassia polysaccharides, particularly F2, revealing their immunomodulatory potential.

## Key findings

- F2 has a main chain of (1 → 4)-linked glucose with minor side chains and terminal residues.
- F2 activates NF-κB and MAPK pathways, increasing nitric oxide and cytokine production in macrophages.
- F2 shows stronger immunomodulatory activity than F1 in vitro.

## Abstract

In this manuscript, we report the successful purification of two polysaccharide fractions (F1 and F2) from Cinnamomum cassia (C. cassia). Their chemical composition analysis revealed carbohydrates (54.8–61.1%), sulfates (8.1–9.5%), proteins (4.8–8.0%), and uronic acids (3.7–3.9%), with molecular weights ranging from 46.1 to 2919.1 kDa. Methylation analysis indicated that the highly active F2 fraction possesses a main chain of (1 → 4)-linked glucose, with minor side chains of (1 → 3)- and (1 → 5)-linked arabinose or (1 → 6)-linked glucose, and terminal glucose/arabinose residues. In vitro experiments demonstrated that F2 significantly enhanced nitric oxide and cytokine (TNF-α, IL-1β, IL-6, IL-10) production in RAW264.7 macrophages through activation of NF-κB and MAPK signaling pathways, exhibiting stronger immunomodulatory activity than F1. These results provide evidence that C. cassia polysaccharides, particularly F2, possess promising potential as natural immunostimulants for functional food or therapeutic applications.

## Linked entities

- **Chemicals:** nitric oxide (PubChem CID 145068), IL-6 (PubChem CID 165368475), IL-10 (PubChem CID 146070)

## Full-text entities

- **Genes:** TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}
- **Chemicals:** sulfates (MESH:D013431), nitric oxide (MESH:D009569), F2 (MESH:D005461), (1   4)-linked glucose (-), Polysaccharides (MESH:D011134), glucose (MESH:D005947), uronic acids (MESH:D014574), arabinose (MESH:D001089), carbohydrates (MESH:D002241)
- **Species:** Cinnamomum aromaticum (species) [taxon 119260]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12984258/full.md

---
Source: https://tomesphere.com/paper/PMC12984258